BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Saturday, April 20, 2024
Home
»
Newsletters
» BioWorld
BioWorld
May 3, 2004
View Archived Issues
Sirna, Immune Response Pad Coffers With Private Placements
Read More
Genta, Allos Both Hurt By FDA Briefing Documents
Two firms scheduled to go before the Oncologic Drugs Advisory panel today took painful financial hits on Friday when FDA reviewers released unfavorable comments about their respective cancer treatments. (BioWorld Today)
Read More
Biogen Idec Earnings Strong At Year's 'High-Water Mark'
Read More
Post-Meal Glucose Hangs Up Aradigm's Diabetes Treatment
Read More
Other News To Note
Read More
Appointments And Advancements
Read More